Brenda I. Jeglinski

Statistics

Publications

Citations

771

H-Index

Active since

2008

Affiliations

Harvard University(Current)

Ironwood Pharmaceuticals (United States)

Beth Israel Deaconess Medical Center

Brenda I. Jeglinski is an author at Harvard University specializing in medicine, chronic constipation pharmacotherapy, and functional gastrointestinal disorders.

Publications per year

2008–2025

Publications

Two Randomized Trials of Linaclotide for Chronic Constipation

Anthony Lembo, Harvey Schneier, Steven J. Shiff et al. · New England Journal of Medicine · 2011 · 372 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy of Linaclotide for Patients With Chronic Constipation

Anthony Lembo, Caroline B. Kurtz, James E. MacDougall et al. · Gastroenterology · 2010 · 235 citations

Medicine, Pharmacology, Pharmacotherapy +10

Pilot Study on the Effect of Linaclotide in Patients With Chronic Constipation

Jeffrey M. Johnston, Caroline B. Kurtz, Douglas A. Drossman et al. · The American Journal of Gastroenterology · 2008 · 119 citations

Medicine, Pharmacology, Pharmacotherapy +17

Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with phenotypic metabolic dysfunction-associated steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial

Rohit Loomba, Kris V. Kowdley, José R Rodríguez-Medina et al. · The Lancet. Gastroenterology & hepatology · 2025 · 30 citations

Medicine, Endocrinology, Pharmacotherapy +11

Safety and pharmacokinetics of the oral iron chelator SP‐420 in β‐thalassemia

Alì Taher, Antoine N. Saliba, Kevin H.M. Kuo et al. · American Journal of Hematology · 2017 · 15 citations · Full text

Medicine, Clinical Pharmacokinetics, Pharmacokinetics +17

1–5 of 5